Convalescent Plasma Therapy use blood transfusion from a person who is recently cured with same illness.
Recently this therapy in used in the treatment of Covid 19. The US FDA has given emergency authorization to treat hospitalized patient and patient with weak immune system.
Mechanism of Plasma Therapy
Person who treated with Covid -19 has more antibodies against virus and when blood is infused in Covid positive patient , antibody start their work by engulfing infected cells and purifying blood with enhancing antibodies level. This process boost immune system to fight against diseases or conditions.
Coding For Convalescent Therapy
C9507 Fresh frozen plasma, high titer COVID-19 convalescent, frozen within 8 hours of collection, each unit.
This process is authorized for treatment of Covid-19 patients with immunosuppressive disease or getting immunosuppressive treatment in the outpatient or inpatient setting.
As we know better in HCPCS Level II code C category is used for Outpatient Prospective Payment System (OPPS) hospitals to report new technology procedures, drugs, biologicals, radiopharmaceuticals, services, and devices that do not have other HCPCS Level II code assignments
How Do Bill C9507
The effective date for Code C9507 is Dec. 28, 2021.
According CMS we should use following information while submitting claims for code C9507 :
- Ambulatory payment classification (APC): 1509 (New Technology – Level 9 ($701 – $800))
- Status indicator: S (Procedure or service, not discounted when multiple/Paid under OPPS; separate APC payment)
- Payment rate: $750.50
Reference: